Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 27 member E3 (FAM27E3) is a protein whose expression is upregulated in various cancers, including papillary thyroid carcinoma, and is associated with metastatic potential and poor prognosis[2]. It is implicated in physiological processes like embryonic development, wound healing, and tissue regeneration, but also pathological processes such as tissue fibrosis and cancer progression[1][2]. Functionally, FAM27E3 modulates the epithelial-mesenchymal transition (EMT), enhances tumor cell invasion and migration, and may promote tumor stemness and multidrug resistance through EMT[2]. Mechanistically, it appears to influence macrophage infiltration and immune microenvironment, and can regulate phosphorylation and activity of the tumor suppressor protein TP53 (p53), which may promote oncogenic phenotypes in tumors[2]. FAM27E3 is suggested as a marker for lymph node metastasis in papillary thyroid carcinoma, but there are currently no known small-molecule or antibody drugs that directly target it[2]. The detailed molecular mechanism and universality of its function in different tumors remain to be clarified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 27 member E3 (FAM27E3).